Venture Capital

A new partnership brings clinically-backed liver support to your daily smoothie, signaling a major shift in the functional beverage market.

A new study reveals a stark divide on what it means to be American, as AAPIs report rising anxiety and a profound disconnect from the general public.

A new partnership aims to accelerate data-driven innovation, tackle productivity gaps, and empower British manufacturers with advanced analytics.

This Gen Z startup's viral AI videos are moving education beyond simple answers, attracting millions of users and major enterprise interest.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

MPS smashes Q1 revenue records, fueled by a 98% surge in its AI data segment. The company now eyes a massive $6 billion capacity expansion.

Contineum Therapeutics reports encouraging early data for its non-opioid drug PIPE-791, offering a potential new weapon in the fight against chronic pain.

With a new CEO who helped build Liquid Death, A-GAME Beverages is betting his CPG playbook can turn the athlete-backed brand into a national powerhouse.

A new partnership aims to make powerful FPGA chips accessible to hobbyists and startups, potentially sparking a new wave of hardware innovation.

As Kodak prepares its Q1 2026 report, investors are watching to see if its pivot to advanced materials can sustain its recent market momentum.

A major expansion of a homegrown school meals program aims to nourish children and boost local economies, turning classrooms into hubs of community growth.

As the grid faces a crisis from decentralization, data centers, and decarbonization, G&W Electric is launching a new intelligence hub to find solutions.

A new partnership with a NASA veteran's VC firm aims to accelerate startups at UCF, turning space-grade innovations into terrestrial solutions.

The Jewish Theological Seminary appoints engagement expert Rabbi Mike Uram, signaling a strategic shift to modernize and expand its reach in a changing world.

Alkeus Pharmaceuticals will present crucial data on its oral drug for Stargardt disease, a leading cause of juvenile blindness with no current cure.

The logistics firm's recognition as a climate leader highlights an industry race where sustainability is now a key competitive and strategic advantage.

A Boston biotech is using AI and targeted mRNA to program cells inside the body, aiming to make complex CAR T treatments safer and universally accessible.

Vortex Energy is advancing its Robinsons River project, aiming to turn ancient salt deposits into vital storage for Canada's burgeoning hydrogen economy.

A new study shows high success for VVT Med's ScleroSafe varicose vein treatment, but a closer look reveals the need for more long-term data.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.